Financials
Financial year 2025
CENTRE DE DIAGNOSTIC ET DE TRAITEMENT CARDIOLOGIQUE from Sint-Genesius-Rode, company number BE0442866267, closed financial year 2025 with a result of € 117,058 after tax. For that financial year CENTRE DE DIAGNOSTIC ET DE TRAITEMENT CARDIOLOGIQUE recorded a gross margin of € 275,515 and equity of € 528,939. Compared with financial year 2024, the result moved from € 121,814 to € 117,058. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 29, 2026.
€ 528,939
▼ 5% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 117,058
▼ 4% vs 2024
Profit after tax over the fiscal year.
€ 232,202
▲ 75% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 145,000 paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
€ 83,071
▲ 1% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 5,017
▼ 71% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 1,713
▲ 12% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 19,751
▼ 9% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 192,407 | € 281,381 | € 290,969 | € 275,515 | ▼ 5% |
| Profit after taxes | € 61,063 | € 123,081 | € 121,814 | € 117,058 | ▼ 4% |
| Equity | € 347,986 | € 471,067 | € 556,881 | € 528,939 | ▼ 5% |
| Total debts | € 38,249 | € 36,667 | € 64,692 | € 168,226 | ▲ 160% |
| Cash | € 119,032 | € 270,326 | € 132,955 | € 232,202 | ▲ 75% |
| Land & buildings | € 163,358 | € 147,424 | € 136,813 | € 129,552 | ▼ 5% |
| Retained profit | € 323,197 | € 446,278 | € 532,092 | € 504,149 | ▼ 5% |
| Dividend | € 0 | € 0 | € 36,000 | € 145,000 | ▲ € 109,000 |
| Bank debt | € 13,845 | € 3,471 | € 0 | € 0 | |
| Balance sheet total | € 386,235 | € 507,733 | € 621,573 | € 697,165 | ▲ 12% |
Key figures of CENTRE DE DIAGNOSTIC ET DE TRAITEMENT CARDIOLOGIQUE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to CENTRE DE DIAGNOSTIC ET DE TRAITEMENT CARDIOLOGIQUE?
What happened at CENTRE DE DIAGNOSTIC ET DE TRAITEMENT CARDIOLOGIQUE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 117,058 (▼ 4% vs 2024). Source: NBB ↗
- New establishment in Sint-Genesius-Rode. KBO
- Start of the company according to the CBE. KBO
- Jean-Paul Melchior became a director. NBB
In short
From € 61,063 profit in 2022 to € 117,058 profit in 2025.
Paid € 181,669 in corporate taxes since 2022.
Best year ever: 2023, with € 123,081 profit.
Paid out € 181,000 in dividends to the owners in total.
A new publication or filing at CENTRE DE DIAGNOSTIC ET DE TRAITEMENT CARDIOLOGIQUE? We notify you, reason included.
Follow CENTRE DE DIAGNOSTIC ET DE TRAITEMENT CARDIOLOGIQUEDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind CENTRE DE DIAGNOSTIC ET DE TRAITEMENT CARDIOLOGIQUE is Jean-Paul Melchior.
Directors
According to the 2025 annual accounts
Jean-Paul Melchior
Director
since 1990
Establishments
Establishment units
Physical locations of this company
Waterloose Steenweg 76
1640 Sint-Genesius-Rode
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0442.866.267
- VAT number
- BE 0442.866.267
- Registered office
- Waterloose Steenweg 76, 1640 Sint-Genesius-Rode
- Names & denominations
- CENTRE DE DIAGNOSTIC ET DE TRAITEMENT CARDIOLOGIQUE · CEDICARD
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 10 January 1991
- Peppol
- Active · Active since 28 May 2025
- Activities · NACE
Activiteiten van medisch specialisten